Angina Pectoris Drugs Market Trends and 2022 Forecast

From: crystal market research
Published: Mon Dec 11 2017

The Angina Pectoris Drugs Market was worth USD 8.24 billion in the year of 2014 and is expected to reach approximately USD 11.35 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 3.62% during the forecast period. The United States commanded angina pectoris drugs market among the seven noteworthy nations. The worldwide angina pectoris market is relied upon to be all things considered driven by interest for malady changing and focused on medicines, expanded consumption on human services and accessibility of powerful treatment strategies over the developing markets. Angina pectoris is a clinical sign identified by precordial heaviness or distress because of transient myocardial ischemia without infarction, evoked by physical effort or mental anxiety. Angina pectoris is classified as - microvascular, stable, unstable and Prinzmetal/variation. Angina pectoris is an underlying introduction of coronary heart disease (CHD) and applies a noteworthy effect on personal satisfaction (QOL). Chronic stable angina pectoris has a predominance of 2.0 - 4.0 percent in the seven noteworthy markets United Kingdom, Italy, Spain, Germany, United States, France, and Japan. Stroke and Heart Disease Statistics from American Heart Association gauges demonstrate that more than nine million adults in the United States have unending angina pectoris. The commonness of angina rises pointedly with age in the two sexual orientations, going from 2.0-5.0 percent in men matured 45-54 to 10.0-20.0 percent in men matured 65-74 and from 0.1-1.0 percent in women aged 45-54 to 10.0-15.0 percent in women aged 65-74.

Get Sample copy of this Report:

Regional Outlook and Trend Analysis

In 2016 The United States ruled the section by representing over 33 percent of the piece of the overall industry. Entrenched healthcare foundation, expanded implementation of therapeutics and existence of key makers in the United States are in charge of its huge share. Besides, expanding frequency of cardiovascular issue because of inactive way of life and supportive administrative activities are filling the market development. China offers solid opportunity for the extension of the market because of expulsion of value tops on all medication classifications, the progressing Healthy China 2020 social insurance change, and strong twelfth Five-Year Plan measures which target biotechnology as key advancement division. Besides, existence of an extensive target populace and solid neglected clinical requirements are a portion of the components that are anticipated to drive the development of this area.

Competitive Insights

The major players in the market are AstraZeneca, GlaxoSmithKline, Sanofi, Pfizer, Gilead Sciences, Eli Lilly and Company and Amgen. The organizations are concentrating on business extension in developing markets or developing locales, for example, China by embracing procedures including mergers and acquisitions for improvement of new products. Biosimilar improvement is developing as a promising business sector opportunity in angina therapeutics. Numerous enoxaparin sodium and abciximabbiosimilars have picked up endorsements in the Indian, United States, European and markets.

The Angina Pectoris Drugs Market is segmented as follows-

By Therapeutic Class:
Calcium Antagonists
Beta Blockers
o ACE inhibitors
o Nitrates
o Anti-anginal (Ranolazine)

Get customization of this Report:

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:

304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: + 1-888-213-4282
Company: crystal market research
Contact Name: Market-Research
Contact Email:

Visit website »